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Objectives: Low-hematocrit bypass is one technique used to prevent allogeneic
transfusion during cardiopulmonary bypass. The purpose of this study is to deter-
mine the efficacy of a criterion-driven transfusion protocol and the effect of
low-hematocrit bypass with moderate hypothermia in pediatric cardiac surgery.
Methods: Seventy-five children who underwent cardiopulmonary bypass with low-
hematocrit bypass for repair of congenital heart disease were studied. Criteria for red
blood cell transfusion included anemia with a hematocrit level of less than 15%
during bypass and 20% after bypass. During cardiopulmonary bypass, venous
oxygen saturation, hematocrit values, and regional cerebral oxygenation were con-
tinuously monitored. Arterial lactate levels were measured postoperatively.
Results: All patients had an uncomplicated perioperative course, and no perioper-
ative death occurred. Twenty-two patients (29.3%) received a transfusion, and 53
(70.7%) patients did not. The hematocrit levels before and after modified ultrafil-
tration in the transfused group (21.6 5.5%, 26.6 6.5%) were significantly higher
than those in the nontransfused group (18.9 3.7%, 23.1 4.1%) (P .05). There
was no significant difference between the group’s arterial lactate levels immediately
after admission to the intensive care unit and 1 day after the operation. The arterial
lactate levels 6 hours after the admission to the intensive care unit for the nontrans-
fused patients were higher than with the transfused patients (4.3  3.0 versus 2.5 
1.5 mmol/L, (P  .05). For arterial lactate level, the relation with patients’ weight
had the highest correlation (R  0.678, P  .0001).
Conclusions: A criterion-driven transfusion program can be effective, and low-
hematocrit bypass with a hematocrit value below 20% may affect lactate production
or clearance from the body.
Anemia remains one of the primary problems seen after cardiacsurgery, especially in the pediatric age group. Whole blood andblood products are used for the treatment of anemia. However,this therapy can potentially cause a variety of complications, suchas transfusion reactions, volume overload, infections,1,2 and in-creased hospital mortality3 and may have poor effects on long-
term survival.4 Because of these risks, clinicians and surgeons are strongly moti-
vated to minimize or avoid allogeneic transfusion.
Low-hematocrit bypass is one technique used to prevent allogeneic transfusion
during cardiopulmonary bypass (CPB). After consistent success with low-hemat-
ocrit bypass in Jehovah’s Witness patients, the lowest hematocrit levels being
between 17.9% and 22.7% during CPB,5-8 many investigators9-11 reported that
low-hematocrit bypass is effective in preventing allogeneic transfusion. These
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investigators also reported that the lowest safe hematocrit
level was approximately 15%. The risks of low-hematocrit
bypass during deep hypothermic circulatory arrest are also
reported.12
The purpose of this study is to determine the efficacy of
a criterion-driven transfusion protocol and the effect of
low-hematocrit bypass with moderate hypothermia in pedi-
atric cardiac surgery.
Patients and Methods
The study was approved by the local ethics committee and all
parents gave written informed consent. A prospective, observa-
tional study was performed on 75 nonconsecutive children who
underwent CPB for repair of congenital heart disease between
January 1999 and August 1999 at Kobe Children’s Hospital.
Children who required deep hypothermic circulatory arrest or
emergency surgery were excluded from this study.
There were 42 (56.0%) boys and 33 (44.0%) girls, with a mean
age of 6.5  4.2 years (range 4 months to 18 years), and a mean
weight of 20.7  13.2 kg (range 4.0-69.3 kg). Forty-eight (64.0%)
patients had acyanotic heart disease, and 27 (36.0%) patients had
cyanotic heart disease.
Patients were placed on CPB with bicaval cannulations and a
single aortic cannula. CPB was performed with a roller pump, and
a hollow-fiber membrane oxygenator was used for gas exchange
(Exceran HPO-20HC; MERA, Tokyo, Japan). The circuit was
primed with 700 to 900 mL of acetate Ringer’s solution depending
on the weight of the patient. If the predicted hematocrit level after
hemodilution was under 15%, red blood cells were added to the
priming solution. In these cases, the priming solution mixed with
red blood cells was rinsed with 1000 mL of bicarbonate Ringer’s
solution using a polymethylmethacrylate (PMMA) hemofilter (He-
mofeel-CH-0.3SL, TORAY; Tokyo, Japan) before CPB. CPB was
instituted at a flow rate of 2.2 to 2.6 L · min1 · m2, and the
perfusate was cooled to induce moderate hypothermia (26°C to
32°C). Blood gas management was performed using the pH-stat
strategy. Before CPB was initiated, 15 mL/kg of autologous blood
was collected from the right atrial cannula, and replaced with the
same amount of hydroxyethylated starch. The autologous blood
was returned to the patient after modified ultrafiltration (MUF).
Myocardial preservation was achieved with intermittent cold blood
cardioplegia composed of a crystalloid cardioplegic solution and
oxygenated blood from the oxygenator. The blood cardioplegic
solution was returned to the cardiotomy reservoir during CPB.
Conventional ultrafiltration (CUF) and MUF were carried out with
a PMMA hemofilter. CUF was begun during the rewarming phase
of CPB with its rate adjusted to reach a cardiotomy reservoir level
that approached zero at the termination of CPB. If red blood cells
were transfused during CPB, dilutional ultrafiltration (DUF) was
performed with 1000 mL of bicarbonate Ringer’s solution as
Bando and associates reported.13 MUF was started after the ter-
mination of CPB with an ultrafiltration rate of 15 to 20 mL/kg in
15 minutes, as we previously reported.14 The heparinization was
neutralized by protamine sulfate until the activated coagulation
time had normalized. The remaining blood in the CPB circuit was
returned to the patient within the operative day. Postoperative
drainage was collected in a water-sealed drainage system; how-
ever, the blood that was shed was not reinfused. Maximal dose of
dopamine and dobutamine, intubation time, and days spent in the
intensive care unit (ICU) were recorded.
Criteria for red blood cell transfusion included anemia with a
hematocrit level of less than 15% during CPB and 20% after CPB.
We monitored mixed venous oxygen saturation (SvO2) during
CPB and maintained the value above 50%. If we had difficulty
maintaining the SvO2 above 50%, despite increasing the pump
flow or oxygen concentration during CPB, we decided to transfuse
the autologous blood or allogeneic blood. If postoperative hemo-
dynamic instability persisted despite sufficient inotropic support,
we decided to transfuse red blood cells even when the hematocrit
level was above 20%. We did not transfuse platelets or fresh frozen
plasma before red blood cell transfusion in this study.
Data used in these analysis included patient age; sex; weight;
CPB time; total cardiac ischemic time; the lowest rectal tempera-
ture; the lowest SvO2 during CPB; alveolar arterial gradient
(AaDO2) just after admission to the ICU; postoperative blood loss.
Arterial blood hematocrit levels before CPB, lowest hematocrit
levels during CPB, hematocrit levels before MUF, after MUF, just
after admission to the intensive care unit (ICU), and 1 day after the
operation were analyzed. The arterial lactate levels were measured
by Lactate Pro (Arkray Factory Inc., KDK Corporation, Kyoto,
Japan) just after admission to the ICU, 6 hours after admission to
the ICU, and 1 day after the operation. The venous oxygen satu-
ration and hematocrit values were continuously monitored through
CPB by an optical hematocrit and SvO2 sensor (Crit-Line monitor,
In-Line Diagnostics, Riverdale, Utah).
In 17 patients, we monitored regional cerebral oxygenation
using near-infrared spectroscopy (TOS 96; Tostec, Tokyo, Japan),
in which two probes were placed on the forehead bilaterally. With
this system, changes in intracranial oxygenation were recorded
every second during the operation. If we had difficulty maintaining
the regional cerebral oxygen saturation above 50%, in conjunction
with the assessment by the SvO2, we also decided to transfuse the
autologous blood or allogeneic blood.
Statistical analyses were performed with a statistical analysis
program (Statview 5.0; Cricket Software, Philadelphia, Pa). All
values were expressed as mean  standard deviation (SD). An
unpaired Student t test, a 2 test for independence, and a Fisher
exact probability test were used to assess the differences between
the two groups. A paired Student t test was used assess the
difference between postoperative changes of arterial lactate levels
in each group. The correlation between differences in lactate levels
and parameters were calculated by linear regression analysis.
Results
All patients had an uncomplicated perioperative course, and
no perioperative death occurred. All patients were dis-
charged from the hospital in good condition. Twenty-two of
75 study patients (29.3%) received a transfusion during their
operation or stay in the ICU. Of the 22 patients who re-
ceived a transfusion, 9 patients received transfusions in the
form of the priming solution because of their low body
weight, 7 patients were transfused to maintain hematocrit
level or mixed venous oxygen saturation, and 6 patients
were transfused because of hemodynamic instability after
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the termination of CPB. The clinical characteristics and
surgical data in the patients with transfusion (group 1) and
without transfusion (group 2) are shown in Table 1. The
transfused patients were younger, smaller, and more likely
to have had cyanotic heart disease. Additionally, the trans-
fused patients had longer CPB time, longer total cardiac
ischemic time, lower rectal temperature, lower SvO2, higher
AaDO2, and required a larger amount of inotropic agents,
longer intubation time, and longer stays in the ICU.
The perioperative hematocrit levels for patients in both
groups are shown in Figure 1. The hematocrit levels before
MUF and after MUF in group 1 (21.6%  5.5%, 26.6% 
6.5%) were significantly higher than that in group 2 (18.9%
 3.7%, 23.1%  4.1%) (P  .05). However, there was no
significant difference between the groups in the other data
points.
The postoperative arterial lactate levels for patients in
both groups are shown in Figure 2. The arterial lactate level
1 day after the operation (1.7  1.0 mmol/L) showed a
significant decrease compared with the baseline (2.6  1.7
mmol/L) in group 1 (P  .05). The arterial lactate levels 6
hours after admission to the ICU (4.3  3.0 mmol/L) and 1
day after the operation (2.0  2.1 mmol/L) had significant
differences when compared with the baseline (3.0  2.1
mmol/L) in group 2 (P  .05). Although there was no
significant difference in the arterial lactate levels just after
admission to the ICU and 1 day after the operation between
the groups, the arterial lactate level 6 hours after admission
to the ICU in group 2 (4.3  3.0 mmol/L) was significantly
higher than that in group 1 (2.5  1.5 mmol/L) (P  .05).
The correlation between the lowest hematocrit level and
the arterial lactate level 6 hours after admission to the ICU
in all patients was not strong (R  0.428, P  .0019). The
correlation coefficients for the relation between each of the
independent variables and the arterial lactate level 6 hours
after admission to the ICU in group 2 are listed in Table 2.
For arterial lactate level, the relation with patients’ weight
had the highest correlation (R  0.678, P  .0001) (Figure
3).
Discussion
During moderate hemodilution, total body oxygen delivery
is maintained because hemodilution reduces blood viscosity
and vascular resistance, resulting in an increase in tissue
blood flow under both CPB15 and non-CPB conditions.16
Cook and associates17 reported that physiologically impor-
tant changes in cerebral oxygen supply might occur at
hematocrit levels of 12% in 18°C, 15% in 28°C, and 18% in
38°C under CPB conditions. Therefore, our criteria for red
blood cell transfusion, including anemia with a hematocrit
level less than 15% during CPB and 20% after CPB, were
reasonable to prevent neurologic complications. Baraka and
associates18 reported the correlation between SvO2 and
changes of body temperature, perfusion flow, and hemato-
crit levels. Croughwell and associates19 reported that there
is a marked increase in cognitive impairment, when jugular
venous oxygen saturation is less than 50% during rewarm-
ing. Therefore, our criterion to transfuse red blood cells
when the SvO2 level was less than 50% was also reasonable.
However, the arterial lactate level 6 hours after admis-
sion to the ICU in group 2 was significantly higher than that
in group 1. The patients in group 1 had a longer CPB time,
longer total cardiac ischemic time, and lower SvO2. The
patients in group 1 also required a larger amount of inotro-
pic agents, longer intubation time, and longer stays in the
ICU. The longer CPB time might be a cause for transfusion
because of hemolysis or blood loss during CPB. Many
investigators reported20-24 that patients with high lactate
levels tend to require a longer CPB time. Lower SvO2
during CPB can also lead to high lactate levels.22 We
believe that the patients in group 1 did not have elevated
lactate levels due to red blood cell transfusion during CPB.
In the case of a complex congenital heart defect, we tend to
transfuse just after the direct confirmation of the intracar-
diac anatomy, and after the determination of the operative
procedures according to the complex defect. Therefore, the
period during which the hematocrit value is maintained at
its lowest level in group 1 might be shorter than that in
group 2. The patients in group 2 might have longer periods
with the lowest hematocrit level. Furthermore, longer CPB
time might result in the comparatively lower body temper-
TABLE 1. Patient characteristics and surgical data
Variable Group 1 Group 2 P value
No. of patients 22 53
Age (y) 3.2 2.5 7.9 4.0  0.01
Sex (male/female) 10/12 32/21 0.24




CPB time (min) 225 74 142 74 0.01
Total cardiac ischemic time
(min)
105 44 62 48 0.01
Lowest rectal temperature
(°C)
27.0 1.4 29.7 2.6 0.01
Lowest SvO2 (%) 57.0 7.8 64.5 15.3 0.05
A-aDO2 (mm Hg) 214.3 97.6 143.7 53.9 0.01
Postoperative blood loss
(mL) 6 h
112.9 67.9 95.5 79.8 0.37
Postoperative blood loss
(mL) 24 h
263.8 174.6 207.6 156.4 0.18
Maximal dose of dopamine
(g · kg1 · min1)
9.2 0.5 7.2 0.4 0.01
Maximal dose of dobutamine
(g · kg1 · min1)
5.6 0.9 1.6 0.4 0.01
Intubation time 24 h  10 (45.5%) 4 (7.5%) 0.01
ICU stay 2 days  20 (90.9%) 23 (43.5%) 0.01
Data are given as mean  SD where indicated.
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ature in the patients with group 1. Not only will a higher
hematocrit level have a greater potential to deliver oxygen
but also a lower body temperature might lead the body to
require less oxygen after CPB.
The arterial lactate level in group 2 rose 6 hours after
admission to the ICU and fell below the level just after
admission to the ICU, at 1 day after the operation, while the
peak lactate level in group 1 was just after admission to the
ICU, and fell along the time course. Ariza and associates25
and Routsi and associates26 reported that the peak lactate
level was measured 3 to 12 hours after admission to the
ICU, while Li and associates24 reported that the peak level
was measured just after admission to the ICU. The progres-
sive elevation in arterial lactate levels during the postoper-
ative period could be caused by the effects of the increasing
metabolic rate through spontaneous rewarming, emergence
from anesthesia, and spontaneous recovery of myocardial
function. Furthermore, it could be caused by the tissue
washout of lactate after an increase in tissue perfusion. The
splanchnic circulation could be a cause of elevation in
lactate level27 during the postoperative period. Finally, the
elevation in lactate could be due to impaired clearance by
the liver. Although we did not confirm the liver clearance
after CPB in this study, the hematologic studies revealed no
significant liver dysfunction in either group.
Our data demonstrated that the linear relationship be-
tween the arterial lactate level 6 hours after admission to the
ICU in group 2 and the body weight showed the most
Figure 1. Perioperative changes in hematocrit levels. *P < .05, group 1 vs group 2.
Figure 2. Postoperative changes in arterial lactate levels. *P < .05, group 1 vs group 2. #P < .05, vs baseline.
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significant correlation among the various variables. Inter-
estingly, the reports25,26 in which the peak lactate level was
measured 3 to 12 hours after admission to the ICU was on
a study on the adult age group, whereas the report24 in
which the peak level was measured just after admission to
the ICU was on a study of patients from the small children
age group (2 months to 15 years; median, 3.75 years). The
progressive elevation in arterial lactate levels during the
postoperative period in group 2 might suggest that there was
lactate accumulation during low-hematocrit CPB and the
difference in the central body temperature after CPB was
attributable to the body weight. Further investigations will
be needed to clarify the progressive elevation in arterial
lactate levels during the postoperative period.
We rinsed the priming blood solution or performed DUF
when we transfused red blood cells, because transfusion of
packed red blood cells leads to a severe burden of hydrogen
ions, carbon dioxide, potassium, glucose, and lactic acid.28
Haynes and associates29 also reported that allogeneic trans-
fusion increased the inflammatory response. Although
longer CPB time and longer total cardiac ischemic time
might have led to the elevation of A-aDO2 in group 1, rinsing
the blood might remove lactate during CPB. This process
might affect the lactate level and lead to a decrease during
the postoperative period.
In our study, venous oxygen saturation, hematocrit val-
ues, and regional cerebral oxygenation were continuously
monitored through CPB. Although the cerebral circulation
is not representative of whole body physiology, the brain
has the highest oxygen demand, lowest oxidative reserve,
and is more prone to significant damage during CPB than
any other organ, especially during low-hematocrit bypass.
Several investigators reported the importance and useful-
ness of cerebral monitoring during cardiac surgery.30,31
Regional cerebral oxygenation status may not always reflect
the postoperative neurologic damage because the minor
changes may only be detected by magnetic resonance im-
aging.32 We could not prove the effectiveness of this tech-
nique with statistical significance in this study because of
the limited number of patients, the method of fitting, the
laterality, and the individual difference of the circumference
of the head. However, this type of serial monitoring might
be necessary during low-hematocrit bypass to prevent neu-
rologic damage.
Mild hyperlactemia is relatively common after CPB,
typically with a range of 2 to 4 mmol/L.24-26 Duke and
associates22 reported that the odds ratios for major adverse
events if the blood lactate level was greater than 4 mmol/L
at 4 and 8 hours were 8.3 and 9.3, respectively. Hatherill
and associates33 reported that an initial lactate level of 6
mmol/L had the best predictive value for mortality. Most
patients of our study did not reach such high lactate levels
and did not have a complicated perioperative course under
our transfusion criteria. However, further investigation will
be needed to clarify the effects of low-hematocrit bypass.
The obvious limitation of our study is that it was a
prospective, observational study, not a prospective, random-
ized study. Therefore, the patient characteristics and surgi-
cal data were different between the two groups. The use-
fulness and the role of cerebral monitoring remain
uncertain. Further studies will be necessary to clarify the
effect of low-hematocrit bypass.
Figure 3. The relationship between body weights and arterial
lactate levels 6 hours after admission to the ICU in group 2.
TABLE 2. Multiple regression analyses of association be-
tween the arterial lactate levels six hours after the admis-
sion to the ICU and the patient characteristics, and the






CPB time 0.149 .3941
Total cardiac ischemic time 0.148 .3946
Lowest hematocrit 0.614 .0001
Lowest rectal temperature 0.041 .8217
Lowest SvO2 0.263 .1272
A-aDO2 0.148 .3954
Postoperative blood loss, 6 h 0.318 .0625
Postoperative blood loss, 24 h 0.373 .0271
Maximal dose of dopamine 0.029 .8671
Maximal dose of dobutamine 0.155 .3729
Intubation time 0.087 .6183
ICU stay 0.100 .5675
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In conclusion, a criterion-driven transfusion program can
be effective, and the arterial lactate level after low-hemat-
ocrit bypass without transfusion is higher than that with
transfusion despite the longer CPB time. Although the pa-
tients did not have complicated perioperative courses, low-
hematocrit bypass with a hematocrit value below 20% may
affect lactate production or clearance from the body.
We thank Michael Kopcak for his editorial advice.
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